Arialys Therapeutics Funding: $58M Raised, Seed (2023)

Arialys Therapeutics funding overview

Arialys Therapeutics is based in La Jolla, Country. Arialys Therapeutics has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in September 2023. The round record for Arialys Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Avalon Ventures, Alexandria Venture Investments, Catalys Pacific, Johnson & Johnson Innovation, MPM Capital. 5 distinct backers are named across the disclosed rounds.

Arialys Therapeutics at a glance

Total raised: $58M
Latest round: Seed
Latest round date: September 2023
Headquarters: La Jolla, Country
Notable investors: Avalon Ventures, Alexandria Venture Investments, Catalys Pacific, Johnson & Johnson Innovation, MPM Capital

Frequently asked about Arialys Therapeutics funding

How much has Arialys Therapeutics raised?: Arialys Therapeutics has raised $58M in total disclosed funding across the rounds on record.
Who has invested in Arialys Therapeutics?: Avalon Ventures, Alexandria Venture Investments, Catalys Pacific, Johnson & Johnson Innovation, MPM Capital are named among the investors backing Arialys Therapeutics.
What was the latest Arialys Therapeutics funding round?: The most recent disclosed round is a Seed, announced in September 2023.
Where is Arialys Therapeutics based?: Arialys Therapeutics is based in La Jolla, Country.
When did Arialys Therapeutics last raise?: The last disclosed Arialys Therapeutics round closed in September 2023 at Seed.

Every Arialys Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in La Jolla at a similar stage.

Arialys Therapeutics Funding: $58M Raised, Seed (2023)

Arialys Therapeutics funding overview

Arialys Therapeutics at a glance

Frequently asked about Arialys Therapeutics funding

Companies related to Arialys Therapeutics (20)

Browse related funding lists (7)